Literature DB >> 30680641

Different doses of methamphetamine alter long-term potentiation, level of BDNF and neuronal apoptosis in the hippocampus of reinstated rats.

Siamak Shahidi1, Alireza Komaki1, Reihaneh Sadeghian2,3, Sara Soleimani Asl4.   

Abstract

Methamphetamine (METH) is a psychostimulant. The precise mechanisms of its effects remain unknown and current relapse treatments have low efficacy. However, brain-derived neurotrophic factor (BDNF) and neuronal plasticity are essential contributors, despite paradoxical reports and a lack of comprehensive studies. Therefore, we investigated the effects of different doses of METH on long-term potentiation (LTP), BDNF expression and neuronal apoptosis in the hippocampus of reinstated rats. Rats were injected intraperitoneally with METH (1, 5, or 10 mg/kg) or saline, and trained in a conditioned place preference paradigm. Following implementation of the reinstatement model, electrophysiology, western blotting and TUNEL assay were performed to assess behavior, LTP components, BDNF expression, and neuronal apoptosis, respectively. The results demonstrated that the preference scores, population spike amplitude and BDNF expression markedly decreased in the METH (10 mg/kg) group compared with the other groups. In contrast, METH (5 mg/kg) significantly increased these factors more than the control group. There was no change in variables between METH (1 mg/kg) and the control group. Also, apoptosis of the hippocampus was increased in the METH (10 mg/kg) group compared with the METH (5 mg/kg) group. These results suggest that alterations in synaptic plasticity, expression of BDNF and neuronal apoptosis in the hippocampus has a vital role in the context-induced reinstatement of METH seeking.

Entities:  

Keywords:  Brain derived neurotrophic factor; Conditioned place preference; Long-term potentiation; Methamphetamine; Neuronal apoptosis; Reinstatement

Mesh:

Substances:

Year:  2019        PMID: 30680641     DOI: 10.1007/s12576-019-00660-1

Source DB:  PubMed          Journal:  J Physiol Sci        ISSN: 1880-6546            Impact factor:   2.781


  75 in total

1.  Decoding BDNF-LTP coupling in cocaine addiction.

Authors:  Li-Min Mao; Eugene E Fibuch; John Q Wang
Journal:  Neuron       Date:  2010-09-09       Impact factor: 17.173

2.  Presynaptic plasticity in an immature neocortical network requires NMDA receptor activation and BDNF release.

Authors:  Corinna Walz; Kay Jüngling; Volkmar Lessmann; Kurt Gottmann
Journal:  J Neurophysiol       Date:  2006-12       Impact factor: 2.714

3.  Minocycline, an antibiotic with inhibitory effect on microglial activation, attenuates the maintenance and reinstatement of methamphetamine-seeking behavior in rat.

Authors:  Ghassem Attarzadeh-Yazdi; Reza Arezoomandan; Abbas Haghparast
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-04-24       Impact factor: 5.067

4.  Electrophysiological properties of Ia excitation and recurrent inhibition in cat abdominal motoneurons.

Authors:  Masatoshi Niwa; Ken Muramatsu; Kiyomi Nakayama; Sei-Ichi Sasaki
Journal:  J Physiol Sci       Date:  2018-10-15       Impact factor: 2.781

5.  Modulatory effects of Ampicillin/Sulbactam on glial glutamate transporters and metabotropic glutamate receptor 1 as well as reinstatement to cocaine-seeking behavior.

Authors:  Alaa M Hammad; Fawaz Alasmari; Yusuf S Althobaiti; Youssef Sari
Journal:  Behav Brain Res       Date:  2017-06-15       Impact factor: 3.332

Review 6.  Neurobiology of the incubation of drug craving.

Authors:  Charles L Pickens; Mikko Airavaara; Florence Theberge; Sanya Fanous; Bruce T Hope; Yavin Shaham
Journal:  Trends Neurosci       Date:  2011-07-20       Impact factor: 13.837

7.  Cocaine inhibits hippocampal long-term potentiation.

Authors:  D A Smith; M Browning; T V Dunwiddie
Journal:  Brain Res       Date:  1993-04-16       Impact factor: 3.252

8.  Potentiation of rewarding properties of morphine by concurrent chemical stimulation of lateral hypothalamus in rats.

Authors:  Leila Zarepour; Alireza Komaki; Siamak Shahidi; Abdolrahman Sarihi; Abbas Haghparast
Journal:  Pharmacol Biochem Behav       Date:  2013-04-09       Impact factor: 3.533

9.  Administration of activated glial condition medium in the nucleus accumbens extended extinction and intensified reinstatement of methamphetamine-induced conditioned place preference.

Authors:  Reza Arezoomandan; Marzieh Moradi; Ghassem Attarzadeh-Yazdi; Carlos Tomaz; Abbas Haghparast
Journal:  Brain Res Bull       Date:  2016-06-23       Impact factor: 4.077

10.  Neuronal plasticity and neurotrophic factors in drug responses.

Authors:  E Castrén; H Antila
Journal:  Mol Psychiatry       Date:  2017-04-11       Impact factor: 15.992

View more
  4 in total

1.  4'-Iodo-α-Pyrrolidinononanophenone Provokes Differentiated SH-SY5Y Cell Apoptosis Through Downregulating Nitric Oxide Production and Bcl-2 Expression.

Authors:  Yuji Sakai; Yoshifumi Morikawa; Yukino Nagao; Junta Hattori; Koichi Suenami; Emiko Yanase; Tomohiro Takayama; Akira Ikari; Toshiyuki Matsunaga
Journal:  Neurotox Res       Date:  2022-07-14       Impact factor: 3.978

Review 2.  Aerobic exercise as a promising nonpharmacological therapy for the treatment of substance use disorders.

Authors:  Gigliola Marrero-Cristobal; Ursula Gelpi-Dominguez; Roberto Morales-Silva; John Alvarado-Torres; Joshua Perez-Torres; Yobet Perez-Perez; Marian Sepulveda-Orengo
Journal:  J Neurosci Res       Date:  2021-12-01       Impact factor: 4.433

3.  Caveolin-1 Expression in the Dorsal Striatum Drives Methamphetamine Addiction-Like Behavior.

Authors:  Yosef Avchalumov; Alison D Kreisler; Wulfran Trenet; Mahasweta Nayak; Brian P Head; Juan C Piña-Crespo; Chitra D Mandyam
Journal:  Int J Mol Sci       Date:  2021-07-30       Impact factor: 6.208

4.  Methamphetamine augments HIV-1 gp120 inhibition of synaptic transmission and plasticity in rat hippocampal slices: Implications for methamphetamine exacerbation of HIV-associated neurocognitive disorders.

Authors:  Ya Zheng; Benjamin Reiner; Jianuo Liu; Linda Xu; Huangui Xiong
Journal:  Neurobiol Dis       Date:  2022-03-22       Impact factor: 7.046

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.